Royce & Associates LP grew its position in shares of Varex Imaging (NASDAQ:VREX – Free Report) by 12.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 980,958 shares of the company’s stock after acquiring an additional 108,165 shares during the quarter. Royce & Associates LP owned about 2.31% of Varex Imaging worth $18,099,000 as of its most recent filing with the SEC.
Several other institutional investors have also modified their holdings of VREX. GAMMA Investing LLC increased its holdings in shares of Varex Imaging by 65.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,657 shares of the company’s stock worth $31,000 after acquiring an additional 655 shares during the period. Integrated Wealth Concepts LLC bought a new stake in Varex Imaging in the 2nd quarter valued at about $32,000. Parallel Advisors LLC lifted its position in Varex Imaging by 307.2% in the 3rd quarter. Parallel Advisors LLC now owns 1,865 shares of the company’s stock valued at $34,000 after purchasing an additional 1,407 shares during the last quarter. Legal & General Group Plc bought a new stake in Varex Imaging in the 2nd quarter valued at about $43,000. Finally, Fortitude Family Office LLC boosted its stake in Varex Imaging by 1,643.6% during the 3rd quarter. Fortitude Family Office LLC now owns 2,441 shares of the company’s stock valued at $45,000 after purchasing an additional 2,301 shares during the period.
Insider Transactions at Varex Imaging
In related news, Director Jay Kunkel sold 8,121 shares of Varex Imaging stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $18.48, for a total transaction of $150,076.08. Following the sale, the director directly owned 15,329 shares in the company, valued at $283,279.92. The trade was a 34.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Shubham Maheshwari sold 130,000 shares of the company’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $18.46, for a total transaction of $2,399,800.00. Following the completion of the sale, the chief financial officer directly owned 139,972 shares of the company’s stock, valued at $2,583,883.12. The trade was a 48.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 4.60% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several research analysts have commented on VREX shares. Sidoti cut shares of Varex Imaging from a “buy” rating to a “neutral” rating and set a $19.00 target price for the company. in a research report on Monday, August 10th. Oppenheimer lowered shares of Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 10th. Weiss Ratings raised Varex Imaging from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Zacks Research cut Varex Imaging from a “strong-buy” rating to a “hold” rating in a report on Monday, July 27th. Finally, B. Riley Financial downgraded Varex Imaging from a “buy” rating to a “hold” rating in a research report on Monday, August 10th. Seven analysts have rated the stock with a Hold rating. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $16.88.
Get Our Latest Stock Report on Varex Imaging
Varex Imaging Stock Performance
Shares of VREX stock opened at $18.10 on Monday. Varex Imaging has a 1 year low of $9.09 and a 1 year high of $18.63. The firm has a market capitalization of $768.53 million, a PE ratio of 34.81 and a beta of 1.02. The stock has a fifty day moving average of $18.45 and a two-hundred day moving average of $13.85. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.53 and a current ratio of 3.38.
Varex Imaging Profile
Varex Imaging Corporation designs and manufactures components used in X-ray imaging systems. Its products include X-ray tubes, digital detectors, image-processing solutions and related software and services for medical and industrial applications. In healthcare, Varex’s components are used in systems for applications such as radiography, computed tomography, mammography and oncology. Its industrial products support inspection and analysis in areas including security screening and nondestructive testing.
Recommended Stories
- Five stocks we like better than Varex Imaging
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging (NASDAQ:VREX – Free Report).
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
